Skip to main content Help with accessibility Skip to main navigation

Secukinumab

Indication

Moderate to Severe Plaque Psoriasis (NICE TA350)
NICE TA 350 - Secukinumab for treating moderate to severe plaque psoriasis
Red

Brand:

Cosentyx ®

Nice TA:

350

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:
Skin

Background

Secukinumab is recommended, as an option for treating adults with plaque psoriasis as per NICE TA 350

 

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Decisions of Lancashire local decision making groups

Red
Red
Red
Red
Red
Red
Red
Red
What do the colours mean?

Last Updated: 01 - Sep - 2015